The risk of early and late cytomegalovirus DNAemia associated with Campath use in stem cell transplant recipients

The risks associated with in vivo and ex vivo use of Campath-1H and -1G in a cohort of 206 stem cell transplant recipients for cytomegalovirus (HCMV) DNAemia have been quantified. DNAemia showed a biphasic incidence pattern with an inflexion at day 60. The first phase had a linear risk rate for HCMV...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Bone Marrow Transplant
Autores principales: Buyck, Hubertus C, Prentice, H Grant, Griffiths, Paul D, Emery, Vincent C
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829098/
https://ncbi.nlm.nih.gov/pubmed/19966846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2009.329
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares